BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.
Wednesday 8 March 2017
BioLargo CEO, Dennis Calvert: Interview at Uptick Newswire to discuss commercial progress
Dennis Calvert, CEO for BioLargo, Inc.(BLGO), returns to the show with Jasyn Blair and they discuss updates to their Odor & Wound Care lines and getting these products to market.
No comments:
Post a Comment